/data/ccms-data/uploads//MSV000079134/ccms_peak/CF fecal study/Data_Fecal/F2_3_RC10_01_3891.mzXML	314	1661	8568	L-Valyl-L-leucyl-L-prolyl-L-valyl-L-prol	7	5.7e-14	651.396	652.4	234.208	M+H	1
/data/ccms-data/uploads//MSV000079134/ccms_peak/CF fecal study/Data_Fecal/F1_4_RA8_01_3855.mzXML	440	1798	2571	Dolastatin_14_Nγ(Asn)-Me	10	2.3e-09	1102.7	552.354	310.83	M+2H	2
/data/ccms-data/uploads//MSV000079134/ccms_peak/CF fecal study/Data_Fecal/F1_6_RA9_01_3856.mzXML	432	2056	2571	Dolastatin_14_Nγ(Asn)-Me	10	1.3e-08	1102.7	552.353	307.59	M+2H	2
/data/ccms-data/uploads//MSV000079134/ccms_peak/CF fecal study/Data_Fecal/F2_6_RC12_01_3894.mzXML	180	1656	8568	L-Valyl-L-leucyl-L-prolyl-L-valyl-L-prol	7	3.1e-16	651.396	652.403	233.796	M+H	1
